– BRTX-100 is the first and only stem cell product candidate cleared to be evaluated in the cervical degenerative disc disease setting – – IND clearance expands Company’s advanced clinical ...
Back pain is the most common complaint in a pain management clinic. This review discusses use of RFA for back pain including facetogenic pain, including cervical and lumbar pain due to sacroiliac ...
BioRestorative Therapies, Inc. announced that the FDA has cleared its Investigational New Drug application for BRTX-100, marking it as the first stem cell product candidate approved for evaluation ...
Verywell Health on MSN1mon
Neck Pain From Sleeping: Why It Happens and How To Prevent ItNeck pain from sleeping is often related to your sleeping position—particularly if you sleep on your stomach. It can also ...
MELVILLE, N.Y., Feb. 27, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical ...
Chronic pain management physicians and patients are always looking for long-term solutions rather than short-lived interventions. There are three main nonsurgical modalities to ablate nervous ...
MELVILLE, N.Y., Feb. 27, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback